ArticleACS nano2025
Strong Emission Enhancement via Dual-Wavelength Coexcitation in YbTm-Doped Upconverting Nanoparticles for Near-Infrared and Subdiffraction Imaging.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Upconversion Luminescence of NaYFNanomaterials (Basel, Switzerland) · 2026Article
- A reflection on "Intriguing aspects of lanthanide luminescence".Chemical science · 2026Article
- Self-Assembly Strategies in Upconversion Nanoparticle-Based Nanocomposites: Structure Designs and Applications.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upconversion (UC) emission in lanthanide-doped nanoparticles is typically excited by a single near-infrared (NIR) wavelength, most commonly around 975 nm, which promotes ground-state absorption by Yb
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.